Saturday, October 17, 2020

Dr Reddy’s receives DCGI’s approval to conduct clinical trial for Sputnik V vaccine in India

In September 2020, Dr. Reddy's and RDIF entered into a partnership to
conduct clinical trials of Sputnik V vaccine and its distribution in
India. As part of the partnership, RDIF shall supply 100 million doses
of the vaccine to Dr. Reddy's upon regulatory approval in India.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-receives-dcgis-approval-to-conduct-clinical-trial-for-sputnik-v-vaccine-in-india/articleshow/78718038.cms

No comments:

Post a Comment